10 studies found for:    kw-0761
Show Display Options
Rank Status Study
1 Recruiting Phase Ia/Ib Multicenter Trial of Mogamulizumab for Advanced or Recurrent Cancer.
Condition: Solid Tumor
Intervention: Biological: Mogamulizumab
2 Completed
Has Results
Phase II Study of KW-0761 in Subjects With CCR4-positive Adult T-cell Leukemia-lymphoma
Condition: Adult T-cell Leukemia-lymphoma
Intervention: Biological: KW-0761
3 Completed
Has Results
Phase I Study of KW-0761 in Relapsed Patients With CCR4-Positive ATL and PTCL
Conditions: Adult T-Cell Leukemia and Lymphoma (ATL);   Adult Peripheral T-Cell Lymphoma (PTCL)
Intervention: Drug: KW-0761
4 Recruiting Study of KW-0761 Versus Vorinostat in Relapsed/Refractory CTCL
Condition: Cutaneous T-Cell Lymphoma
Interventions: Biological: KW-0761;   Drug: Vorinostat
5 Completed Multicenter, Randomized, Open-label, Parallel-group Study to Compare mLSG15 + KW-0761 to mLSG15
Condition: Adult T-cell Leukemia-Lymphoma
Interventions: Drug: VCAP/AMP/VECP(mLSG15);   Biological: KW-0761
6 Completed Study of KW-0761 in Subjects With CCR4-positive Peripheral T/NK-cell Lymphoma
Condition: Peripheral T/NK-cell Lymphoma
Intervention: Biological: KW-0761
7 Active, not recruiting Study of KW-0761 (Mogamulizumab) in Subjects With Previously Treated Peripheral T-cell Lymphoma (PTCL)
Condition: Peripheral T-Cell Lymphoma
Intervention: Biological: KW-0761 (mogamulizumab)
8 Recruiting KW 0761 or Investigator's Choice in Subjects With Previously Treated Adult T-cell Leukemia-Lymphoma (ATL)
Condition: Adult T-cell Leukemia-Lymphoma
Interventions: Biological: KW-0761;   Drug: investigator's choice (pralatrexate; gemcitabine/oxaliplatin; dexamethasone/cisplatin/cytarabine))
9 Completed Safety Study to Evaluate Monoclonal Antibody KW-0761 in Subjects With Peripheral T-cell Lymphoma
Condition: Peripheral T-Cell Lymphoma
Intervention: Biological: KW-0761
10 Completed Extension Study in Subjects Who Relapsed After Complete Response on Study KW-0761-001
Conditions: Peripheral T-cell Lymphoma;   Cutaneous T-cell Lymphoma
Intervention: Biological: KW-0761

Indicates status has not been verified in more than two years